Ami Neuberger
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 16
- Epidemiology 22
- Sepsis Diagnosis and Treatment 8
- Pneumonia and Respiratory Infections 3
- Co-authors
- Mical Paul (18 shared papers)Dafna Yahav (6 shared papers)Khetam Hussein (6 shared papers)Roni Bitterman (7 shared papers)Joseph Okebe (1 shared paper)Marty Richardson (1 shared paper)Ayelet Raz‐Pasteur (3 shared papers)Eli Schwartz (13 shared papers)
In The Last Decade
Ami Neuberger
79 papers receiving 2.2k citations
Ami Neuberger's Hit Papers
Peers
Comparison fields: 5 of 107
- Applied Microbiology and Biotechnology 293
- Molecular Medicine 604
- Critical Care and Intensive Care Medicine 128
- Microbiology 137
- Endocrinology 78
Countries citing papers authored by Ami Neuberger
This map shows the geographic impact of Ami Neuberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Neuberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Neuberger more than expected).
Fields of papers citing papers by Ami Neuberger
This network shows the impact of papers produced by Ami Neuberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Neuberger. The network helps show where Ami Neuberger may publish in the future.
Co-authors
The 25 scholars most cited alongside Ami Neuberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial Hit paper breakdown → | 2018 | 339 |
| 2 | 2016 | 124 | |
| 3 | 2013 | 122 | |
| 4 | 2018 | 121 | |
| 5 | 2015 | 120 | |
| 6 | 2018 | 102 | |
| 7 | 2017 | 95 | |
| 8 | 2013 | 79 | |
| 9 | 2014 | 75 | |
| 10 | 2020 | 64 | |
| 11 | 2020 | 56 | |
| 12 | 2013 | 53 | |
| 13 | 2015 | 51 | |
| 14 | 2018 | 47 | |
| 15 | 2019 | 46 | |
| 16 | 2015 | 39 | |
| 17 | 2018 | 37 | |
| 18 | 2016 | 33 | |
| 19 | 2017 | 31 | |
| 20 | 2012 | 27 |
About Ami Neuberger
Ami Neuberger is a scholar working on Molecular Medicine, Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health and Applied Microbiology and Biotechnology, having authored 84 papers that have together received 2.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (16 papers), Sepsis Diagnosis and Treatment (8 papers), Malaria Research and Control (5 papers), Bacterial Infections and Vaccines (4 papers), COVID-19 Clinical Research Studies (4 papers), Antibiotic Use and Resistance (4 papers), Pneumonia and Respiratory Infections (3 papers) and Mosquito-borne diseases and control (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (293 citations), Molecular Medicine (604 citations), Critical Care and Intensive Care Medicine (128 citations), Microbiology (137 citations) and Endocrinology (78 citations). Ami Neuberger has collaborated with scholars based in Israel, Italy and Greece. Frequent co-authors include Mical Paul, Dafna Yahav, Khetam Hussein, Roni Bitterman, Joseph Okebe, Marty Richardson, Ayelet Raz‐Pasteur, Eli Schwartz, Ben Shofty and Yuval Geffen. Their work appears in journals such as Clinical Microbiology and Infection, Journal of Travel Medicine, Clinical Infectious Diseases, Cochrane Database of Systematic Reviews and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.